Previous Close | 36.49 |
Open | 36.39 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1800 |
Day's Range | 35.35 - 37.97 |
52 Week Range | 20.24 - 143.08 |
Volume | |
Avg. Volume | 481,066 |
Market Cap | 1.331B |
Beta (5Y Monthly) | 1.24 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -8.35 |
Earnings Date | Aug 08, 2022 - Aug 12, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 57.11 |
Subscribe to Yahoo Finance Plus to view Fair Value for RETA
Insiders who bought Reata Pharmaceuticals, Inc. ( NASDAQ:RETA ) stock lover the last 12 months are probably not as...
Reata Pharmaceuticals, Inc. (RETA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Reata's (RETA) prospects are likely to improve following the potential approval of its lead candidate, omaveloxolone, expected by the end of 2022 is likely driving its share price.